Cardiovascular epidemiology in a changing world - Challenges to investigators and the National Heart, Lung, and Blood Institute

American Journal of Epidemiology

Volumn 175, Issue 7, 2012, Pages 597-601

  Sorlie, Paul D ^a   Bild, Diane E ^a   Lauer, Michael S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Cardiovascular diseases; Epidemiology; National Institutes of Health (U.S.); Research

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; HEALTH PRACTITIONER; INFORMATION TECHNOLOGY; MEDICAL RESEARCH; MEDICAL SOCIETY; NATIONAL HEALTH ORGANIZATION; NOTE; SCIENCE; SCIENTIFIC LITERATURE;

CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC STUDIES; HUMANS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); RESEARCH; UNITED STATES;

EID: 84859495993     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws138     Document Type: Note

References (33)

1. Khatib F, DiMaio F, Cooper S, et al. Crystal structure of a monomeric retroviral protease solved by protein folding game players. Nat Struct Mol Biol. 2011;18(10):1175-1177.
2. Boyle A. Gamers Solve Molecular Puzzle That Baffled Scientists. NewYork,NY:MSNBC; 2011. (http://cosmiclog.msnbc.msn. com/-news/2011/09/16/ 7802623-gamers-solve-molecular-puzzle- that-baffled-scientists). (Accessed January 27, 2012).
3. Kuller LH. Circular epidemiology. Am J Epidemiol. 1999;150(9): 897-903.
4. Ioannidis JP, Tarone R, McLaughlin JK. The false-positive to false-negative ratio in epidemiologic studies. Epidemiology. 2011;22(4):450-456.
5. Nabel EG. National Heart, Lung, and Blood Institute: transitions. Circulation. 2009;119(10):1453-1455.
6. National Institutes of Health. Enhancing Peer Review at NIH. Bethesda, MD: National Institutes of Health; 2011. (http:// enhancing-peer-review.nih.gov. (Accessed December 5, 2011).
7. Chambless LE, Folsom AR, Sharrett AR, et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol. 2003;56(9):880-890.
8. Ridker PM, Paynter NP, Rifai N, et al. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 2008;118(22):2243-2251.
9. National Heart, Lung, and Blood Institute. Shaping the Future of Research: A Strategic Plan for the National Heart, Lung, and Blood Institute. Bethesda, MD: National Heart, Lung and Blood Institute; 2007. (NIH publication no. 07-6150).
10. National Heart, Lung, and Blood Institute. Working Group Summary. The Next Step Population Studies in the "-OMIC" Age. Bethesda, MD: National Heart, Lung, and Blood Institute; 2005. (http://www.nhlbi.nih.gov/ meetings/workshops/population.htm. (Accessed December 6, 2011).
11. Benjamin EJ, Chen PS, Bild DE, et al. Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation. 2009;119(4):606-618.
12. Khoury MJ, McBride CM, Schully SD, et al. The Scientific Foundation for Personal Genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med. 2009;11(8):559-567.
13. Kaltman JR, Thompson PD, Lantos J, et al. Screening for sudden cardiac death in the young: report from a National Heart, Lung, and Blood Institute working group. Circulation. 2011;123(17):1911-1918.
14. Califf RM, Ginsburg GS. Organizational improvements to enhance modern clinical epidemiology. JAMA. 2008;300(19):2300-2302.
15. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155- 2165.
16. Persell SD, Wright JM, Thompson JA, et al. Assessing the validity of national quality measures for coronary artery disease using an electronic health record. Arch Intern Med. 2006;166(20):2272-2277.
17. Banerjee D, Chung S, Wong EC, et al. Underdiagnosis of hypertension using electronic health records. Am J Hypertens. 2012;25(1):97-102.
18. Howard VJ, Cushman M, Pulley L, et al. The Reasons for Geographic and Racial Differences in Stroke Study: objectives and design. Neuroepidemiology. 2005;25(3):135-143.
19. Collins FS, Manolio TA. Merging and emerging cohorts: necessary but not sufficient. Nature. 2007;445(7125):259.
20. Willett WC, Blot WJ, Colditz GA, et al. Merging and emerging cohorts: not worth the wait. Nature. 2007;445(7125):257-258.
21. Gaziano JM. The evolution of population science: advent of the mega cohort. JAMA. 2010;304(20):2288-2289.
22. Allen NE, Beral V, Casabonne D, et al. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst. 2009;101(5):296-305.
23. Rosansky SJ, Eggers PW. Trends in the US end-stage renal disease population: 1973-1983. AmJ Kidney Dis. 1987;9(2):91-97.
24. Krumholz HM, Herrin J, Miller LE, et al. Improvements in door-to-balloon time in the United States, 2005 to 2010. Circulation. 2011;124(9):1038-1045.
25. Kohane IS. Using electronic health records to drive discovery in disease genomics. Nat Rev Genet. 2011;12(6):417-428.
26. Kho AN, Pacheco JA, Peissig PL, et al. Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med. 2011;3(79):79rel.
27. Fröbert O, Lagerqvist B, Gudnason T, et al. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish Angiography and Angioplasty Registry (SCAAR) platform. Study design and rationale. Am Heart J. 2010;160(6):1042-1048.
28. Lauer MS, Hodes R. Epidemiology, comparative effectiveness research, and the National Institutes of Health: forces for health. Epidemiology. 2011;22(5):625-628.
29. Bartecchi C, Alsever RN, Nevin-Woods C, et al. Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation. 2006;114(14):1490-1496.
30. Ioannidis JP.Whymost published researchfindings are false.PLoS Med. 2005;2(8):e124. (doi:10.1371/journal.pmed.0020124).
31. Lauer MS. Thought exercises on accountability and performance-measures at the National Heart,Lung, and Blood Institute (NHLBI): an invited commentary for circulation research. Circ Res. 2011;108(4):405-409.
32. Rosbash M. A threat to medical innovation [editorial]. Science. 2011;333(6039):136.
33. Lauer MS. What now with screening electrocardiography? Ann Intern Med. 2011;155(6):395-397.